Cepheid (CPHD) Announces Weak Prelim. Q3 Results; Trims FY15 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Piper Jaffray Cuts Price Target on Cepheid (CPHD) Following Preliminary 3Q Results
October 14, 2015 9:12 AM EDTPiper Jaffray maintained an Overweight rating on Cepheid (NASDAQ: CPHD), and cut the price target to $62.00 (from $66.00), following the company's preliminary 3Q15 results. CPHD reported revenue of ~$126.5M (Street: $127.9M) and GAAP EPS of ($0.32) (Street: ($0.23)). Management lowered 4Q15 revenue guidance to $146M- $150M (was... More
Leerink Partners Cuts Price Target on Cepheid (CPHD) Following 3Q Pre-Announcement
October 14, 2015 8:42 AM EDTLeerink Partners reiterated a Market Perform rating on Cepheid (NASDAQ: CPHD), and cut the price target to $44.00 (from $58.00), following the company's 3Q pre-announcement and guidance reduction. For 3Q, CPHD guided to revenue of ~$126.5M, ~1% below consensus, and GAAP EPS of ($0.32), below the consensus of... More
Needham & Company Cuts Price Target on Cepheid (CPHD) to $47 Following Pre-Announced 3Q Results
October 14, 2015 8:12 AM EDTNeedham & Company maintained a Buy rating on Cepheid (NASDAQ: CPHD), and cut the price target to $47.00 (from $70.00), following the company's pre-announced 3Q15 results. CPHD now expects 3Q15 sales of $126.5M (up 13% Y/Y CC) vs. consensus of $127.9M and non-GAAP EPS of ($0.13) vs. consensus of... More
Raymond James Downgrades Cepheid (CPHD) to Market Perform
October 14, 2015 6:53 AM EDTRaymond James downgraded Cepheid (NASDAQ: CPHD) from Outperform to Market Perform and removed its price target (prior $67.00).
For an analyst ratings summary and ratings history on Cepheid click here. For more ratings news on Cepheid click here.
Shares of Cepheid closed at $39.61 yesterday.
... More